Abstract
We report here the ultrastructural changes in the third advanced larval stage (AL3) of Gnathostoma binucleatum Almeyda-Artigas, 1991, induced by in vitro treatment with albendazole and the metabolite albendazole sulfoxide. During the whole period of the experiment, the controls remained active and vital throughout the 108-h exposure period. The primary site of action of both drugs appears to be the mitochondria and myofibrils of the polymyarian musculature. Degenerative changes in the secretory portion of the esophagus and somatic musculature were clearly observed. These degenerative changes, leading to complete muscular and glandular necrosis, were interpreted as the consequence of drug-induced blockade of metabolic energy production. Cuticular disruption had also been observed in the experimental groups. We observed a dramatic reduction in the number of mitochondria and muscle fibers, as well as the formation of large autophagic vesicles as result of an irreversible degenerative phenomenon. The passive cutaneous elimination of larvae in human infections is probably a consequence of parasite immobility, due to the effects of this antihelminthic drug.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
